Bispecific anti-GPRC5D antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bispecific anti-GPRC5D antibodies, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study [NA]